No Data
Wall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 99.89%: Read This Before Placing a Bet
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
Sector Update: Health Care Stocks Mixed Premarket Tuesday
Health care stocks were mixed premarket Tuesday, with the Health Care Select Sector SPDR Fund (XLV) was 0.1% higher and the iShares Biotechnology ETF (IBB) was down 0.5% recently. Viridian Therapeutic
Arcutis Biotherapeutics Says Experimental Cream Showed Improvements in Atopic Dermatitis Symptoms
Arcutis Biotherapeutics (ARQT) said Monday its experimental roflumilast cream 0.15% showed continued improvements in the signs and symptoms of atopic dermatitis, including itch, through 56 weeks of tr
Express News | Arcutis Biotherapeutics Inc: Once-Daily, Roflumilast Cream 0.15% Was Well Tolerated
loading...